These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1616360)

  • 1. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.
    Sileghem A; Geusens P; Dequeker J
    Ann Rheum Dis; 1992 Jun; 51(6):761-4. PubMed ID: 1616360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Rizzoli R; Sigaud A; Azria M; Herrmann FR
    Osteoporos Int; 2015 Jan; 26(1):383-93. PubMed ID: 25566730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.
    Huusko TM; Karppi P; Kautiainen H; Suominen H; Avikainen V; Sulkava R
    Calcif Tissue Int; 2002 Dec; 71(6):478-84. PubMed ID: 12370798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bone loss in early nonsurgical and nonosteoporotic high turnover patients with salmon calcitonin: the role of biochemical bone markers in monitoring high turnover patients under calcitonin treatment.
    Lyritis GP; Magiasis B; Tsakalakos N
    Calcif Tissue Int; 1995 Jan; 56(1):38-41. PubMed ID: 7796344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
    Peichl P; Rintelen B; Kumpan W; Bröll H
    Gynecol Endocrinol; 1999 Feb; 13(1):7-14. PubMed ID: 10368793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?
    Kotaniemi A; Piirainen H; Paimela L; Leirisalo-Repo M; Uoti-Reilama K; Lahdentausta P; Ruotsalainen P; Kataja M; Väisänen E; Kurki P
    J Rheumatol; 1996 Nov; 23(11):1875-9. PubMed ID: 8923359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new biochemical marker of bone resorption for follow-up on treatment with nasal salmon calcitonin.
    Overgaard K; Christiansen C
    Calcif Tissue Int; 1996 Jul; 59(1):12-6. PubMed ID: 8661977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
    Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
    J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover.
    van der Wiel HE; Lips P; Nauta J; Kwakkel G; Hazenberg G; Netelenbos JC; van der Vijgh WJ
    J Bone Miner Res; 1993 Dec; 8(12):1459-65. PubMed ID: 8304047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised placebo-controlled trial on the effectiveness of nasal salmon calcitonin in the treatment of lumbar spinal stenosis.
    Tafazal SI; Ng L; Sell P
    Eur Spine J; 2007 Feb; 16(2):207-12. PubMed ID: 16865379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different doses of nasal salmon calcitonin on bone mass.
    Thamsborg G; Storm TL; Sykulski R; Brinch E; Nielsen HK; Sørensen OH
    Calcif Tissue Int; 1991 May; 48(5):302-7. PubMed ID: 2054714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effect of nasal salmon calcitonin during the early post-fracture period of the distal radius fracture.
    Karponis A; Rizou S; Pallis D; Zafeiris CP; Georgiou DF; Galanos A; Giannoulis F; Lyritis GP
    J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):186-9. PubMed ID: 26032211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K; Ravn P; Hansen MA; Christiansen C
    Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.